Premium
Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance
Author(s) -
Abdella N. A.,
Mojiminiyi O. A.,
Moussa M. A.,
Zaki M.,
Al Mohammedi H.,
Al Ozairi E. S. S.,
Al Jebely S.
Publication year - 2005
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/j.1464-5491.2004.01405.x
Subject(s) - medicine , insulin resistance , microalbuminuria , endocrinology , leptin , diabetes mellitus , type 2 diabetes , obesity , blood pressure , insulin , waist , type 2 diabetes mellitus , risk factor
Aims The aim of this study was to evaluate the relationship of obesity, leptin, insulin resistance and C‐reactive protein (CRP) with coronary heart disease (CHD) risk factors in patients with Type 2 diabetes mellitus (DM) with CHD compared with those with Type 2 DM without CHD. Methods Leptin, CRP (high sensitivity assay), fasting plasma insulin, glucose, HbA 1c and full lipid profile were determined in 58 Type 2 diabetic patients with CHD and 87 Type 2 DM patients without CHD. Results were compared between those with and without CHD. Univariate correlation as well as logistic regression analyses were used to relate these markers with traditional CHD risk factors. Results Leptin showed significant correlations with BMI ( r = 0.59; P ≤ 0.0001), waist circumference ( r = 0.45; P < 0.0001), CRP ( r = 0.36; P < 0.0001), and fasting insulin ( r = 0.53; P < 0.0001) as well as with systolic ( r = 0.23; P = 0.007) and diastolic ( r = 0.23; P = 0.007) blood pressure. However, when those with and without CHD were compared only age ( P < 0.0001), duration of diabetes ( P < 0.001) and degree of microalbuminuria ( P = 0.02) were significantly higher in patients with CHD. Leptin ( P = 0.49), CRP ( P = 0.19) and lipid parameters were not significantly different between the two groups. Conclusion Our study confirms a relationship between leptin and CRP with CHD risk factors. The lack of significant difference when patients with and without CHD are compared may be due to the potential confounding effects of treatment with aspirin and statins.